Enter your username/e-mail and your new password will be send to you.
| Title | Union of Light-Ion Centres in Europe |
| Grant Agreement Number | 228436 |
| Funding Programmes | FP7 |
| Dates | 01/09/2009 - 31/08/2013 |
| Project URL | http://ulice.web.cern.ch/ULICE/cms/index. php?file=home |
| Scientific Domain |
Biological and Medical Sciences |
| Activity | Integrating activities |
| Action Line | Integrated Activity |
| Transnational Access | Yes |
| Type Of Project | CP-CSA-INFRA |
| Abstract | ULICE is a 4-year project set up by 20 leading European research organisations, including 2 leading European industrial partners (Siemens and IBA), to respond to the need for greater access to hadron therapy facilities for particle therapy research. Project coordinator is the Italian Research Infrastructure Facility CNAO (Milan). Both existing European Hadron Research Facilities in Heidelberg and Milan are partner and together with the next operational centre (Philipps-Universitat Marburg; yr4) they will provide 624 hours of beam-time (141 users, 52 projects) to external researchers. Future facilities like MedAustron, Etoile and Archade also participate in ULICE, which will result in a strong integrated network. Full exploitation of all different resources, unrestricted spread of information and the improvement of existing and upcoming facilities are provided by using grid-based data sharing. The project is built around 3 pillars with measurable outputs. These outputs will be exploited by the (future) facilities and (partly by) the industrial partners: 1. JRA - focus on development of instruments and protocols: new gantry design, improvement of four-dimensional particle beam delivery, adaptive treatment planning, mechanisms for patient selection to the whole European Community and database development for specific tumours which can best be treated using carbon ion. 2. Networking - increasing cooperation between facilities and research communities wanting to work with the research infrastructure. Outputs will be (among others): a report on recommendations for strategically optimal locations for future RIs throughout Europe, training to new users 3. Transnational access: 2-step approach, using a combination of pre-defined (within ULICE) clinical trial programmes to allow researchers with patients to visit the facility, and radiobiological and physics experiments to take place. |
|
Coordinator
(Organisation name and Country) |
Fondazione Centro Nazionale di Adroterapia Oncologica - Fondazione CNAO, Italy |
|
Partners
(Organisation name and Country) |
THE HENRYK NIEWODNICZANSKI INSTITUTE OF NUCLEAR PHYSICS, POLISH ACADEMY OF SCIENCES, Poland KAROLINSKA INSTITUTET, Sweden UNIVERSITE CATHOLIQUE DE LOUVAIN, Belgium GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH, Germany UNIVERSITAETSKLINIKUM HEIDELBERG, Germany UNIVERSITE LYON 1 CLAUDE BERNARD, France SIEMENS AG, Germany PHILIPPS UNIVERSITAET MARBURG, Germany MEDIZINISCHE UNIVERSITAET WIEN, Austria STICHTING KATHOLIEKE UNIVERSITEIT, Netherlands EBG (Entwicklungs- und Betriebsgesellschaft) MedAustron GmbH, Austria TECHNISCHE UNIVERSITAET DRESDEN, Germany European Society for Therapeutic Radiology and Oncology, Belgium AARHUS UNIVERSITETSHOSPITAL, Denmark ION BEAM APPLICATIONS SA, Belgium ARCHADE, France THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, United Kingdom |
| TA Call | Union of Light-Ion Centres in Europe |
